647932796	647932796	CD	B-NP	O
|	|	NN	I-NP	O
TH	TH	NN	I-NP	O
|	|	NN	I-NP	O
12604079	12604079	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2607770	2607770	CD	B-NP	O
|	|	CC	I-NP	O
3/25/2003	3/25/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/25/2003	3/25/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NNP	B-NP	O
:	:	:	O	O
DEANGELO	DEANGELO	NNP	B-NP	O
MACK	MACK	NNP	I-NP	O
PEED	PEED	NNP	I-NP	O
MD	MD	NNP	I-NP	O
Ms.	Ms.	NNP	I-NP	O
Mulready	Mulready	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
90	90	CD	I-NP	O
+	+	SYM	I-NP	O
-	-	HYPH	I-NP	O
year-old	year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
including	include	VBG	B-PP	O
a	a	DT	B-NP	O
non	non	JJ	I-NP	O
ST	ST	NN	I-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
in	in	IN	B-PP	O
4/13	4/13	CD	B-NP	O
medically	medically	RB	B-VP	O
managed	manage	VBN	I-VP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	I-NP	O
severe	severe	JJ	I-NP	O
aortic	aortic	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
valve	valve	JJ	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
1.0	1.0	CD	B-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Ime	Ime	NNP	I-NP	O
Tesion	Tesion	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
from	from	IN	B-PP	O
that	that	DT	B-NP	O
hospital	hospital	NN	I-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
,	,	,	O	O
a	a	DT	B-NP	O
multilevel	multilevel	JJ	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
and	and	CC	I-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
hospitalized	hospitalize	VBN	I-VP	O
at	at	IN	B-PP	O
Ham11	Ham11	NNP	B-NP	O
Eghe	Eghe	NNP	I-NP	O
Torsa	Torsa	NNP	I-NP	O
Health	Health	NNP	I-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
and	and	CC	O	O
after	after	IN	B-SBAR	O
treatment	treatment	NN	B-NP	O
had	have	VBD	B-VP	O
returned	return	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
facility/skilled	facility/skille	VBD	B-VP	O
nursing	nursing	NN	B-NP	O
facility	facility	NN	I-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
eating	eat	VBG	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
very	very	RB	B-ADJP	O
tachypneic	tachypneic	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
diaphoretic	diaphoretic	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
tachycardiac	tachycardiac	JJ	I-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
here	here	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
night	night	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
readmitted	readmitte	VBN	I-VP	O
to	to	TO	B-PP	O
Nordi	Nordi	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
worsening	worsen	VBG	I-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
with	with	IN	B-PP	O
symptomatic	symptomatic	JJ	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
with	with	IN	B-PP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
20s	20s	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
diuresis	diuresis	NN	B-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
MRA	MRA	NN	I-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
pulmonary	pulmonary	JJ	B-NP	O
embolism	embolism	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	I-VP	O
Redd	Redd	VB	I-VP	O
Hospital	Hospital	NN	B-NP	O
for	for	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Toprol	Toprol	NNP	I-NP	O
XL	XL	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

Temperature	Temperature	NN	B-NP	B-protein
96.5	96.5	CD	I-NP	I-protein
,	,	,	O	O
pulse	pulse	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
70s	70	NNS	I-NP	B-DNA
and	and	CC	I-NP	I-DNA
80s	80	NNS	I-NP	I-DNA
,	,	,	O	O
pressure	pressure	NN	B-NP	O
140/80	140/80	CD	I-NP	O
,	,	,	O	O
breathing	breathe	VBG	B-VP	O
a	a	DT	B-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
four	four	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

Exam	Exam	NN	B-NP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
awake	awake	NN	I-NP	O
,	,	,	O	O
alert	alert	NN	B-NP	O
,	,	,	O	O
pleasant	pleasant	VB	B-VP	O
older	old	JJR	B-NP	O
women	woman	NNS	I-NP	O
,	,	,	O	O
very	very	RB	B-ADVP	O
hard	hard	RB	I-ADVP	O
of	of	IN	B-PP	O
hearing	hearing	NN	B-NP	O
,	,	,	O	O
decreased	decrease	VBN	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
with	with	IN	B-PP	O
rhonchi	rhonchi	NN	B-NP	O
right	right	RB	B-ADVP	O
greater	great	JJR	I-ADVP	O
than	than	IN	B-PP	O
left	left	JJ	B-ADJP	O
and	and	CC	O	O
decreased	decrease	VBN	B-VP	O
breath	breath	NN	B-NP	O
sounds	sound	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
middle	middle	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
,	,	,	O	O
poor	poor	JJ	B-NP	O
inspiratory	inspiratory	JJ	I-NP	O
effort	effort	NN	I-NP	O
.	.	.	O	O

Exam	Exam	NN	B-NP	O
also	also	RB	B-ADVP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
hard	hard	JJ	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
,	,	,	O	O
crescendo	crescendo	NN	B-NP	O
decrescendo	decrescendo	NN	I-NP	O
heard	hear	VBD	B-VP	O
best	well	RBS	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
carotids	carotid	NNS	I-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
audible	audible	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
12	12	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
labs	lab	NNS	I-NP	O
were	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
2.7	2.7	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
slightly	slightly	RB	I-NP	O
elevated	elevated	JJ	I-NP	O
dedimer	dedimer	NN	I-NP	O
at	at	IN	B-PP	O
Hen	Hen	NNP	B-NP	O
Mekend	Mekend	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
middle	middle	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
resolving	resolve	VBG	I-VP	O
,	,	,	O	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
elevation	elevation	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	B-protein
troponins	troponin	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
after	after	IN	B-SBAR	O
admission	admission	NN	B-NP	O
thought	think	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
perhaps	perhaps	RB	I-ADJP	O
to	to	TO	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
or	or	CC	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
low	low	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
keeping	keep	VBG	B-VP	O
atropine	atropine	NN	B-NP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
bedside	bedside	NN	I-NP	O
in	in	IN	B-PP	O
case	case	NN	B-NP	O
of	of	IN	B-PP	O
symptomatic	symptomatic	JJ	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
occasionally	occasionally	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
40s	40	NNS	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
asymptomatic	asymptomatic	JJ	I-NP	O
bradycardia	bradycardia	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
several	several	JJ	B-NP	O
runs	run	NNS	I-NP	O
of	of	IN	B-PP	O
non-sustained	non-sustained	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
diminished	diminish	VBN	B-VP	O
with	with	IN	B-PP	O
repletion	repletion	NN	B-NP	O
of	of	IN	B-PP	O
magnesium	magnesium	NN	B-NP	O
and	and	CC	O	O
again	again	RB	B-ADVP	O
were	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
electrophysiology	electrophysiology	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
feel	feel	VB	I-VP	O
that	that	IN	B-SBAR	O
any	any	DT	B-NP	O
intervention	intervention	NN	I-NP	O
was	be	VBD	B-VP	O
indicated	indicate	VBN	I-VP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
asymptomatic	asymptomatic	JJ	I-NP	O
nature	nature	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
reason	reason	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
tachypnea	tachypnea	NN	I-NP	O
and	and	CC	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
gently	gently	RB	I-VP	O
given	give	VBN	I-VP	O
her	her	PRP$	B-NP	O
aortic	aortic	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
and	and	CC	O	O
tolerated	tolerate	VBD	B-VP	O
well	well	RB	B-ADVP	O
a	a	DT	B-NP	O
net	net	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
500	500	CD	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
1000	1000	CD	I-NP	O
cc	cc	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
with	with	IN	B-PP	O
great	great	JJ	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
comfort	comfort	NN	I-NP	O
breathing	breathing	NN	I-NP	O
.	.	.	O	O

Notably	Notably	RB	B-ADVP	O
she	she	PRP	B-NP	O
never	never	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
oxygen	oxygen	NN	I-NP	O
requirement	requirement	NN	I-NP	O
even	even	RB	B-ADVP	O
when	when	WRB	I-ADVP	O
tachypneic	tachypneic	JJ	B-ADVP	O
.	.	.	O	O

We	We	PRP	B-NP	O
will	will	MD	B-VP	O
do	do	VB	I-VP	O
a	a	DT	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
before	before	IN	B-PP	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
and	and	CC	O	O
send	send	VB	B-VP	O
her	her	PRP	B-NP	O
out	out	RP	B-PRT	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
skilled	skilled	JJ	I-NP	O
nursing	nursing	NN	I-NP	O
facility	facility	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
follow	follow	NN	I-NP	O
up	up	RP	B-PRT	O
appointment	appointment	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Erin	Erin	NNP	I-NP	O
Bahadue	Bahadue	NNP	I-NP	O
at	at	IN	B-PP	O
Oer	Oer	NNP	B-NP	O
Healthcare	Healthcare	NNP	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
persistent	persistent	JJ	I-NP	O
right	right	JJ	I-NP	O
middle	middle	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
process	process	NN	I-NP	O
an	an	DT	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
had	have	VBD	B-VP	O
increasing	increase	VBG	I-VP	O
tachypnea	tachypnea	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
fluid	fluid	JJ	B-NP	O
overloaded	overloaded	JJ	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
gently	gently	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
as	as	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
earlier	earlier	RBR	B-ADVP	O
.	.	.	O	O

Because	Because	IN	B-SBAR	O
a	a	DT	B-NP	O
recurrence	recurrence	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
,	,	,	O	O
we	we	PRP	B-NP	O
will	will	MD	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
14-day	14-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
concern	concern	NN	I-NP	O
of	of	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
to	to	TO	B-VP	O
add	add	VB	I-VP	O
anaerobic	anaerobic	JJ	B-NP	O
coverage	coverage	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
has	have	VBZ	B-VP	O
improved	improve	VBN	I-VP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
2.0	2.0	CD	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
replaced	replace	VBN	I-VP	O
her	her	PRP$	B-NP	O
magnesium	magnesium	NN	I-NP	O
and	and	CC	O	O
put	put	VBD	B-VP	O
her	her	PRP	B-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
daily	daily	JJ	B-NP	O
K-Dur	K-Dur	NN	I-NP	O
10	10	CD	I-NP	O
mEq	mEq	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
to	to	TO	B-VP	O
compensate	compensate	VB	I-VP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
Lasix	Lasix	NNP	I-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
speech	speech	NN	I-NP	O
and	and	CC	O	O
swallow	swallow	VB	B-VP	O
service	service	NN	B-NP	O
.	.	.	O	O

Their	Their	PRP$	B-NP	O
recommendations	recommendation	NNS	I-NP	O
were	be	VBD	B-VP	O
mechanical	mechanical	JJ	B-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
solid	solid	JJ	I-NP	O
diet	diet	NN	I-NP	O
with	with	IN	B-PP	O
thin	thin	JJ	B-NP	O
liquids	liquid	NNS	I-NP	O
,	,	,	O	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
bed	bed	NN	B-NP	O
at	at	IN	B-PP	O
all	all	DT	B-NP	O
meals	meal	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
Flagyl	Flagyl	NN	B-NP	O
to	to	TO	B-VP	O
finish	finish	VB	I-VP	O
a	a	DT	B-NP	O
14-day	14-day	JJ	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
to	to	TO	B-VP	O
finish	finish	VB	I-VP	O
a	a	DT	B-NP	O
14-day	14-day	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
taken	take	VBN	I-VP	O
until	until	IN	B-PP	O
1/29/03	1/29/03	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Flagyl	Flagyl	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
taken	take	VBN	I-VP	O
until	until	IN	B-PP	O
8/30/03	8/30/03	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
salicylic	salicylic	JJ	I-NP	O
acid	acid	NN	I-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
Phoslo	Phoslo	NN	B-NP	O
667	667	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
for	for	IN	B-PP	O
prophylaxis	prophylaxis	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
inpatient	inpatient	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
treated	treat	VBN	I-VP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
MVCMC	MVCMC	NN	B-NP	O
policies	policy	NNS	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
,	,	,	O	O
simvastatin	simvastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
K-Dur	K-Dur	NNP	B-NP	O
10	10	CD	I-NP	O
mEq	mEq	NN	I-NP	O
x1	x1	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
EH	EH	NN	I-NP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

Thank	Thank	VB	B-VP	O
you	you	PRP	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
opportunity	opportunity	NN	I-NP	O
to	to	TO	B-VP	O
care	care	VB	I-VP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
lovely	lovely	JJ	I-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
8-2244235	8-2244235	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
FRATZKE	FRATZKE	NNP	B-NP	O
,	,	,	O	O
KORY	KORY	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KARAGIANNIS	KARAGIANNIS	NNP	B-NP	O
,	,	,	O	O
VALENTINE	VALENTINE	NNP	B-NP	O
ROOSEVELT	ROOSEVELT	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
8031463	8031463	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
9/9/03	9/9/03	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
9/9/03	9/9/03	CD	B-NP	O

